What is Ionis Pharmaceuticals's FX effect on cash?

Ionis Pharmaceuticals (IONS) reported FX effect on cash of -$138K in Q1 2026.

How has Ionis Pharmaceuticals's FX effect on cash changed year-over-year?

Ionis Pharmaceuticals's FX effect on cash decreased by 159.5% year-over-year, from $232K to -$138K.

Ionis Pharmaceuticals IONS FX Effect on Cash

FX Effect on Cash at other companies

Eli LillyLLY

$67M-49.2%

PfizerPFE

$19M+371%

Arrowhead ResearchARWR

$997K+348%

Roivant SciencesROIV

$1.32M—

AbbVieABBV

-$12M-233%

ALN

Alnylam PharmaceuticalsALNY

——

Other financials

Income statement

See full

Revenue$246.1M+87.0%

Gross profit$243.1M+86.8%

Operating income-$117.4M+20.0%

Net income-$92.5M+37.0%

EPS (diluted)-$0.56+39.8%

Balance sheet

See full

Cash & equivalents$173.4M-34.4%

Total debt$691.7M+334%

Total equity$491.4M+3.3%

Total assets$3.4B+22.6%

Cash flow

See full

Operating cash flow-$792.8M-426%

CapEx$21.8M+73.0%

Free cash flow-$814.6M-399%

Valuation

See full

Market cap$12.25B+159%

Enterprise value$12.77B+175%

P/S11.6×+5.0×

Profitability

See full

Gross margin98.4%-0.2pp

Operating margin-33.3%-11.0pp

Net margin-30.9%-10.5pp

FCF margin-77.4%+35.3pp

Returns & leverage

See full

Return on equity-67.6%-20.3pp

Debt / equity1.4×+1.1×

Current ratio4.1×-5.6×

Where this comes from

Reported directly by Ionis Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ionis Pharmaceuticals's fx effect on cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ionis Pharmaceuticals's FX effect on cash?: Ionis Pharmaceuticals (IONS) reported FX effect on cash of -$138K in Q1 2026.
How has Ionis Pharmaceuticals's FX effect on cash changed year-over-year?: Ionis Pharmaceuticals's FX effect on cash decreased by 159.5% year-over-year, from $232K to -$138K.